- Home
- ENV vs RVNC Comparison
ENV vs RVNC Comparison
Compare ENV & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENV
- RVNC
- Stock Information
- Founded
- ENV 1999
- RVNC 1999
- Country
- ENV United States
- RVNC United States
- Employees
- ENV N/A
- RVNC N/A
- Industry
- ENV Business Services
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- ENV Consumer Discretionary
- RVNC Health Care
- Exchange
- ENV Nasdaq
- RVNC Nasdaq
- Market Cap
- ENV N/A
- RVNC 546.4M
- IPO Year
- ENV 2010
- RVNC 2014
- Fundamental
- Price
- ENV $62.78
- RVNC $5.14
- Analyst Decision
- ENV Hold
- RVNC Buy
- Analyst Count
- ENV 8
- RVNC 10
- Target Price
- ENV $61.88
- RVNC $10.86
- AVG Volume (30 Days)
- ENV 843.7K
- RVNC 2.6M
- Earning Date
- ENV 11-06-2024
- RVNC 11-06-2024
- Dividend Yield
- ENV N/A
- RVNC N/A
- EPS Growth
- ENV N/A
- RVNC N/A
- EPS
- ENV N/A
- RVNC N/A
- Revenue
- ENV $1,307,702,000.00
- RVNC $251,178,000.00
- Revenue This Year
- ENV $11.83
- RVNC $20.36
- Revenue Next Year
- ENV $10.12
- RVNC $31.66
- P/E Ratio
- ENV N/A
- RVNC N/A
- Revenue Growth
- ENV 8.01
- RVNC 40.23
- 52 Week Low
- ENV $33.12
- RVNC $2.30
- 52 Week High
- ENV $73.04
- RVNC $9.90
- Technical
- Relative Strength Index (RSI)
- ENV 59.11
- RVNC 35.31
- Support Level
- ENV $62.57
- RVNC $5.13
- Resistance Level
- ENV $62.73
- RVNC $5.41
- Average True Range (ATR)
- ENV 0.09
- RVNC 0.19
- MACD
- ENV 0.01
- RVNC -0.02
- Stochastic Oscillator
- ENV 100.00
- RVNC 25.49
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.